This website uses cookies

We use cookies and website tracking tools to provide you with the best online experience. Learn more in our /en/privacy-notice/privacy statement.

if you accept, your choice will be valid until cancellation.

If you disallow cookies, functionality of our website might be limited.


Press releases

One mutation - one medicine

For the first time in Europe, Tübingen physicians make use of an RNA therapy specifically tailored to one patient

Press release in German only

Press contact
Press contactDirector of Communications
Dr. Mareike KardinalPhone 07071 29 88800mareike.kardinal@medizin.uni-tuebingen.deAddress

Hertie Institute for Clinical Brain Research
Director of Communications

Otfried-Müller-Str. 27
72076 Tübingen